Literature DB >> 1700122

Biliary bypass and palliation for pancreatic cancer.

C D Johnson.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 1700122      PMCID： PMC1292793          DOI： 10.1177/014107689008300828

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial.

Authors:  H A Shepherd; G Royle; A P Ross; A Diba; M Arthur; D Colin-Jones
Journal:  Br J Surg       Date:  1988-12       Impact factor: 6.939

2.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

3.  The role of prophylactic gastrojejunostomy for unresectable periampullary carcinoma.

Authors:  S W Blievernicht; J P Neifeld; J J Terz; W Lawrence
Journal:  Surg Gynecol Obstet       Date:  1980-12

4.  Carcinoma of the head of the pancreas: bypass surgery in unresectable disease.

Authors:  G La Ferla; W R Murray
Journal:  Br J Surg       Date:  1987-03       Impact factor: 6.939

5.  Surgical management of unresectable carcinoma of the pancreas.

Authors:  M G Sarr; J L Cameron
Journal:  Surgery       Date:  1982-02       Impact factor: 3.982

6.  Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy.

Authors:  A M Gardner; G Solomou
Journal:  Ann R Coll Surg Engl       Date:  1984-11       Impact factor: 1.891
  6 in total
  1 in total

1.  Endoscopic ultrasound-guided transduodenal placement of a fully covered metal stent for palliative biliary drainage in patients with malignant biliary obstruction.

Authors:  Ali A Siddiqui; Jayaprakash Sreenarasimhaiah; Luis F Lara; William Harford; Calvin Lee; Mohamad A Eloubeidi
Journal:  Surg Endosc       Date:  2010-07-15       Impact factor: 4.584
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.